Reaction Details Report a problem with these data
Target
Rat vasopressin-neurophysin
Ligand
BDBM50133817
Substrate
n/a
Ki
>10000±n/a nM
Comments
PDSP_7569
Citation
Valenzano, KJ; Grant, ER; Wu, G; Hachicha, M; Schmid, L; Tafesse, L; Sun, Q; Rotshteyn, Y; Francis, J; Limberis, J; Malik, S; Whittemore, ER; Hodges, D N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. J Pharmacol Exp Ther 306:377-86 (2003) [PubMed] Article
More Info.:
Target
Name:
Rat vasopressin-neurophysin
Synonyms:
Rat preprovasopressin-neurophysin | VASOPRESSIN V1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
2826.33
Organism:
RAT
Description:
VASOPRESSIN V1 0 RAT::Q6LEI5
Residue:
26
Sequence:
MLNTTLSACFLSLLALTSACYFQNCP
Inhibitor
Name:
BDBM50133817
Synonyms:
4-(3-Chloro-pyridin-2-yl)-piperazine-1-carboxylic acid (4-tert-butyl-phenyl)-amide | BCTC | CHEMBL441472 | N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)piperazine-1-carboxamide
Type:
Small organic molecule
Emp. Form.:
C20H25ClN4O
Mol. Mass.:
372.892
SMILES:
CC(C)(C)c1ccc(NC(=O)N2CCN(CC2)c2ncccc2Cl)cc1